| Mosholu Parkway Nursing & Rehabilitation Center | |
| 3356 Perry Avenue, Bronx, New York 10467 | |
| (718) 655-3568 | |
| Name | Mosholu Parkway Nursing & Rehabilitation Center |
|---|---|
| Location | 3356 Perry Avenue, Bronx, New York |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 122 |
| Occupancy Rate | 81.15% |
| Medicare ID (CCN) | 335030 |
| Legal Business Name | Mosholu Parkway Nursing And Rehabilitation Center |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1861481566 |
| Organization Name | MOSHOLU PARKWAY NURSING AND REHABILITATION CENTER |
| Address | 3356 Perry Ave, Bronx, NY 10467 |
| Phone Number | 718-655-3568 |
News Archive
Curtailing the imminent rise in Alzheimer's disease (AD) will require early, accurate diagnostic tests and treatments, and researchers are closer to achieving these two goals. New findings in medical imaging, molecular analysis of neurological diseases, and development of treatments using mouse models were presented at Neuroscience 2012, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news about brain science and health.
Ark Biosciences, a biotech company developing proprietary therapeutics for viral infection and respiratory diseases, announced today the significant progress in its phase 2 proof-of-concept study of ziresovir in the treatment of hospitalized RSV infected infants.
Aerospace giant Boeing tested two kinds of ionization technologies — like those widely adopted in schools hoping to combat covid — to determine how well each killed germs on surfaces and decided that neither was effective enough to install on its commercial planes.
A recent clinical trial found that the adult antiviral drug, tenofovir disoproxil fumarate (tenofovir DF), is safe and effective in treating adolescents with hepatitis B virus (HBV). Trial results published in the December issue of Hepatology, a journal of the American Association for the Study of Liver Diseases (AASLD), show that tenofovir DF suppressed HBV in 89% of pediatric participants.
› Verified 2 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Curtailing the imminent rise in Alzheimer's disease (AD) will require early, accurate diagnostic tests and treatments, and researchers are closer to achieving these two goals. New findings in medical imaging, molecular analysis of neurological diseases, and development of treatments using mouse models were presented at Neuroscience 2012, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news about brain science and health.
Ark Biosciences, a biotech company developing proprietary therapeutics for viral infection and respiratory diseases, announced today the significant progress in its phase 2 proof-of-concept study of ziresovir in the treatment of hospitalized RSV infected infants.
Aerospace giant Boeing tested two kinds of ionization technologies — like those widely adopted in schools hoping to combat covid — to determine how well each killed germs on surfaces and decided that neither was effective enough to install on its commercial planes.
A recent clinical trial found that the adult antiviral drug, tenofovir disoproxil fumarate (tenofovir DF), is safe and effective in treating adolescents with hepatitis B virus (HBV). Trial results published in the December issue of Hepatology, a journal of the American Association for the Study of Liver Diseases (AASLD), show that tenofovir DF suppressed HBV in 89% of pediatric participants.
› Verified 2 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 22.59 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 11.08 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 64.12 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.33 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 4.51 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 2.77 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 1.54 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 71.79 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 2.12 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 12.5 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 1.56 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 20.3 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 2.32 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 17.74 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 94.38 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 69.62 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 44.21 | 82.93 |
News Archive
Curtailing the imminent rise in Alzheimer's disease (AD) will require early, accurate diagnostic tests and treatments, and researchers are closer to achieving these two goals. New findings in medical imaging, molecular analysis of neurological diseases, and development of treatments using mouse models were presented at Neuroscience 2012, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news about brain science and health.
Ark Biosciences, a biotech company developing proprietary therapeutics for viral infection and respiratory diseases, announced today the significant progress in its phase 2 proof-of-concept study of ziresovir in the treatment of hospitalized RSV infected infants.
Aerospace giant Boeing tested two kinds of ionization technologies — like those widely adopted in schools hoping to combat covid — to determine how well each killed germs on surfaces and decided that neither was effective enough to install on its commercial planes.
A recent clinical trial found that the adult antiviral drug, tenofovir disoproxil fumarate (tenofovir DF), is safe and effective in treating adolescents with hepatitis B virus (HBV). Trial results published in the December issue of Hepatology, a journal of the American Association for the Study of Liver Diseases (AASLD), show that tenofovir DF suppressed HBV in 89% of pediatric participants.
› Verified 2 days ago
Schervier Nursing Care Center Location: 2975 Independence Ave, Bronx, New York 10463 Phone: (718) 548-1700 | |
The Citadel Rehab And Nursing Ctr At Kingsbridge Location: 3400 -26 Cannon Place, Bronx, New York 10463 Phone: (718) 796-8100 | |
Mosholu Parkway Nursing & Rehabilitation Center Location: 3356 Perry Avenue, Bronx, New York 10467 Phone: (718) 655-3568 | |
Williamsbridge Center For Rehabilitation And Nrsg Location: 1540 Tomlinson Avenue, Bronx, New York 10461 Phone: (718) 892-6600 |